The company was once in the hands of Clayton, Dubilier & Rice before being sold to Willis Towers Watson for $1.3bn in 2019.

Stellex Capital Management is one company that sees M&A potential in the UK construction materials and services as it aims to ...

Lunettes Pour Tous is an optical retailer offering eyewear made in-store in 10 minutes. ODDO BHF plans to strengthen its portfolio in Germany, as it picks up an investment in Lunettes Pour Tous in ...

The firm announced the acquisition of Fox Brothers, an integrated services and materials provider, in late September.

LDC has exited its investment in Ensek, a digital transformation services provider in the energy sector, to Centrica. Nottingham, UK-based Ensek, founded in 2010, has a billing and customer account ...

Bain Capital has made an investment into Chartbeat, a portfolio company of Cuadrilla Capital. Bain Capital’s Private Credit Group will now join Cuadrilla as an institutional investor in Chartbeat.

This is La Bottega’s third M&A transaction in the past year The hospitality market is forecast to reach €22 billion by 2028 Three Hills has €3 billion of assets under management Three Hills-backed La ...

An exclusive on an acquisition VSS Capital Partners is expected to announce today involving Treya Partners; inside Renovus ...

Riverside Company -backed OutSolve has invested in Labor Law Center, a labor law compliance services provider. Labor Law Center’s existing investor Kian Capital will become a significant minority ...

Ambienta portfolio company Cap Vert Group has finalized the acquisition of N2B Arrosage, a French company specialized in the management of watering system works for green urban areas. Founded in 1986 ...

Inconto is Whitevision’s first add on since Main acquired the company in August. Whitevision, founded in 2005 and based in Breda, the Netherlands, is a developer and provider of software to process ...

DRI Capital’s affiliate DRI Healthcare Trust has acquired a portion of Editas Medicine’s payment rights under a license to Vertex Pharmaceuticals of the former’s Cas9 gene-editing technology for ...